Dorothy Teegarden
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
188
Citations
4,867
Est. group size
~12
Recurring co-author estimate
Active years
48
Publishing since 1979
Dorothy Teegarden's research focuses on how vitamin D (specifically 1,25-dihydroxyvitamin D) affects the metabolism and progression of breast cancer cells, including how cancer cells adapt their energy production (such as fatty acid synthesis and glutamine use) when spreading to other tissues like bone and lungs. Her group also studies related nutrition topics, such as obesity and maternal diet effects on offspring, and has contributed to interdisciplinary undergraduate education efforts around nutrition science.
Publication output has grown substantially over the past decade, rising from around 3-5 papers per year in the late 2010s to a peak of 20 in 2024, with an average of nearly 9 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 2326: Differential lipid metabolism in mammary cancer cell progression
Cancer Research · 2021
- Abstract 2327: Pyruvate carboxylase rescues MCF10A-<i>ras</i> cell viability in extracellular matrix detached conditions
Cancer Research · 2021
- Abstract 2873: Comparison of metastatic and nonmetastatic breast cancer cell survival in glutamine depleted extracellular matrix detached conditions
Cancer Research · 2021
- Abstract 2571: 1,25-dihydroxyvitamin D regulation of pyruvate carboxylase in MCF10A-ras cells decreases viability in extracellular matrix detached conditions
Cancer Research · 2020
- Increasing undergraduate interdisciplinary exposure through an interdisciplinary web-based video series
Innovations in Education and Teaching International · 2019
- Transdisciplinary Obesity Prevention Research Sciences (TOPRS) Curriculum Increases Knowledge About Complex Causes and Consequences of Obesity for Undergraduate Students
Frontiers in Public Health · 2019
- Regulation of Vitamin D Receptor by 1,25-dihydroxyvitamin D in Breast Cancer (P05-013-19)
Current Developments in Nutrition · 2019
- 1, 25-Dihydroxyvitamin D3 Altered Metabolism of MCF10A-ras Cells Decreases Viability in Extracellular Matrix Detached Conditions (FS13-05-19)
Current Developments in Nutrition · 2019
- Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer
Breast Cancer Research · 2018
- Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2018
- Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression
Cancer Letters · 2017
- 1α,25‐dihydroxyvitamin D <sub>3</sub> Inhibits Adipocyte Mediated Metastatic Capability of Breast Cancer Cells
The FASEB Journal · 2017
- 1α,25‐Dihydroxyvitamin D <sub>3</sub> Inhibits <i>De Novo</i> Fatty Acid Synthesis and Neutral Lipid Accumulation in Metastatic Breast Cancer Cells Through Downregulation of Pyruvate Carboxylase
The FASEB Journal · 2017
- 1α,25‐dihydroxyvitamin D <sub>3</sub> Inhibits Matrix Metalloprotease 2 Expression in Metastatic Breast Cancer Cells
The FASEB Journal · 2017
- Pyruvate Carboxylase is Essential for Breast Cancer Metastasis <i>in Vivo</i>
The FASEB Journal · 2017
- Cancer Research×23
- The FASEB Journal×9
- Current Developments in Nutrition×5
- UNC Libraries×4
- Cancer & Metabolism×3
- Madeline P. Sheeley
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Chaylen Andolino
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Eylem Kulkoyluoglu‐Cotul
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Jiliang Li
Biochemistry, Genetics and Molecular Biology · Indiana University
- Charles E. Dann
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile